Hormone replacement therapy: why are general practitioners not prescribing more?

Area of Science:

• General Practice
• Endocrinology
• Public Health

Background:

• Hormone replacement therapy (HRT) is widely discussed and advocated in medical literature.
• Recent statistics indicate a low prescription rate among general practitioners (GPs).
• Understanding the reasons behind this prescribing gap is crucial for patient care and public health.

Purpose of the Study:

• To investigate the reasons for the low prescription rates of hormone replacement therapy (HRT) by general practitioners (GPs).
• To explore factors influencing HRT prescribing practices among GPs in South Birmingham.
• To identify potential disparities in HRT prescribing based on GP demographics and patient populations.

Main Methods:

• A questionnaire survey was distributed to 200 randomly selected general practices in South Birmingham in March 1997.
• Eighty-one completed questionnaires (40.5% response rate) were analyzed.
• Data collected included GP demographics, HRT prescribing habits, and perceived knowledge of HRT risks and benefits.

Main Results:

• A high percentage of responding GPs (86.4%) actively prescribed HRT for osteoporosis prophylaxis.
• Most GPs (76%) believed they were well-informed about HRT's risks and benefits.
• Significant differences were observed in opinions on HRT duration between male and female GPs, and notable variations in ethnic backgrounds of prescribers versus non-prescribers and their patient populations.

Conclusions:

• Despite perceived knowledge, factors influencing HRT prescription rates among GPs require further investigation.
• Demographic factors, including GP gender and ethnicity, and patient population characteristics may play a role in HRT prescribing patterns.
• Addressing these disparities could improve the appropriate utilization of hormone replacement therapy.